Overview
Study A - MK0767 Monotherapy Study
Status:
Terminated
Terminated
Trial end date:
2003-11-01
2003-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to test if MK0767 lowers blood glucose after 20 weeks compared to placebo. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.
Criteria
Inclusion Criteria:- Patients with Type 2 Diabetes
- Non-pregnant females and patients who agree not to become pregnant during the study
Exclusion Criteria:
- Patients with Type 1 Diabetes
- Patients who have been treated with insulin or other antihyperglycemic agents
- Patients with viral hepatitis, active liver or gallbladder disease, history of
pancreatitis, heart disease, congestive heart failure, inadequately controlled
hypertension, HIV positive, history hematologic disorders or neoplastic disease